Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05240131
Title A Study to Investigate the Safety and Efficacy of GB1211 (a Galectin-3 Inhibitor) in Combination With Atezolizumab in Patients With Non-Small Cell Lung Cancer (NSCLC).
Recruitment Recruiting
Gender
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Galecto Biotech AB
Indications
Therapies
Age Groups: adult | senior
Covered Countries ITA | FRA | ESP

Facility Status City State Zip Country Details
Centre Georges Grancois Leclerc RECRUITING Dijon 21000 France Details
Hôpital Arnaud de Villeneuve RECRUITING Montpellier 34295 France Details
CHRU RECRUITING Tours 37044 France Details
Ospedale Santa Maria delle Croci RECRUITING Ravenna 48121 Italy Details
Samodzielny Publiczny Zespol Gruzlicy I Chorob Pluc RECRUITING Olsztyn 10-357 Poland Details
Grupa Medyczna Med-Polonia RECRUITING Poznań 60-693 Poland Details
ICO-Badalona ( Germans Trial I Pujol) RECRUITING Barcelona Badalona 08916 Spain Details
Hospital Universitario y Politécnico La Fe RECRUITING Valencia València 46026 Spain Details
Hospital Universitari Vall d'Hebron RECRUITING Barcelona 08035 Spain Details
Hospital Universitario 12 de Octubre RECRUITING Madrid 28041 Spain Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field